ESC Premium Access

Modeling ischemic heart disease: Only matured human iPS-derived cardiomyocytes are sensitive to ischemic injury

Topic: Ischaemia, Infarction, Cardioprotection

Presentation

About the speaker

Doctor Marijn Peters

University Medical Center Utrecht, Utrecht (Netherlands (The))
0 follower

202 more presentations in this session

Monounsaturated fatty acid antagonizes saturated fatty acid-induced cardiomyopathy via improving membrane fatty acid composition and endoplasmic reticulum stress

Speaker: Doctor T. Yamamoto (Tokyo, JP)

Thumbnail

MicroRNA let-7a, -7e and -133a attenuate hypoxia-induced atrial fibrosis via targeting collagen expression and the JNK pathway in HL1 cardiomyocytes

Speaker: Doctor C. Lo (Taichung, TW)

Thumbnail

Acute administration of the olive constituent, oleuropein, combined with post-conditioning mechanism exerts cardioprotective effects by modulating oxidative defense

Speaker: Professor I. Andreadou (Athens, GR)

Thumbnail

Coronary artery cavitation as a trigger for atherosclerotic plaque progression: a numerical and computational fluid dynamic demonstration

Speaker: Associate Professor G. Rigatelli (Rovigo, IT)

Thumbnail

Melatonin receptor blockade slows ventricular conduction by IK1 downregulation

Speaker: Doctor M. Gonotkov (Syktyvkar, RU)

Thumbnail

Access the full session

Basic science e-posters

Speakers: Doctor M. Peters, Doctor T. Yamamoto, Doctor C. Lo, Professor I. Andreadou, Associate Professor G. Rigatelli...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Empagliflozin reduces TNFa-induced reactive oxygen species through inhibition of the human endothelial Na+/H+ exchanger 1

27 August 2021

ESC Premium Access

PCSK9 inhibition with alirocumab decreases plasma lipoprotein(a) concentration by a dual kinetic mechanism of action

27 August 2021

ESC Premium Access

Glucagon-like peptide-1 receptor agonist and the relation between metabolic effects and cardiovascular outcomes: insight into mechanisms of action

27 August 2021

This platform is supported by

logo Novo Nordisk